TY - JOUR
T1 - Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors
AU - Lee, Jong Hwa
AU - El-Fakahany, Esam E.
PY - 1985/4/2
Y1 - 1985/4/2
N2 - In the present studies, we investigate the binding properties of [3H]quinuclidinyl benzilate ([3H]QNB) and [3H]N-methylscopolamine ([3H]NMS) to muscarinic acetylcholine receptors (mAChR) in rat brain homogenates. Our results indicate that the hydrophilic receptor ligand, [3H]NMS, is able to interact with high affinity only with a fraction of the receptor sites available to the lipophilic ligand, [3H]QNB. Furthermore, displacement experiments demonstrated that while both unlabeled QNB and NMS displaced [3H]NMS binding according to the law of mass-action, NMS, but not QNB, displayed binding heterogeneity when [3H]QNB was used as a ligand. Our data suggest that the lipid solubility of a particular mAChR ligand might play an important role in determining its profile of binding to the receptor.
AB - In the present studies, we investigate the binding properties of [3H]quinuclidinyl benzilate ([3H]QNB) and [3H]N-methylscopolamine ([3H]NMS) to muscarinic acetylcholine receptors (mAChR) in rat brain homogenates. Our results indicate that the hydrophilic receptor ligand, [3H]NMS, is able to interact with high affinity only with a fraction of the receptor sites available to the lipophilic ligand, [3H]QNB. Furthermore, displacement experiments demonstrated that while both unlabeled QNB and NMS displaced [3H]NMS binding according to the law of mass-action, NMS, but not QNB, displayed binding heterogeneity when [3H]QNB was used as a ligand. Our data suggest that the lipid solubility of a particular mAChR ligand might play an important role in determining its profile of binding to the receptor.
KW - Muscarinic receptors
KW - Receptor heterogeneity
KW - [H]N-Methylscopolamine
KW - [H]Quinuclidinyl benzilate
UR - http://www.scopus.com/inward/record.url?scp=0021893318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021893318&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(85)90221-3
DO - 10.1016/0014-2999(85)90221-3
M3 - Article
C2 - 3987816
AN - SCOPUS:0021893318
VL - 110
SP - 263
EP - 266
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
SN - 0014-2999
IS - 2
ER -